An inverse probability weighting method for estimating the net benefit in survival analyses in observational studies 
Abstract
Background: Recently, in the context of randomized trials, a measure on the difference scale called the net benefit was developed for survival analysis. As this measure does not require the assumption of proportional hazards, it is an attractive new measure of the treatment effect to apply instead of the hazard ratio calculated under this assumption. However, no method for estimating it has been presented in observational studies. Therefore, we describe a simple method to estimate the net benefit adjusted for confounding.
Methods: We reviewed a method for estimating the net benefit in a randomized trial and extended it to a method that adjusts for confounding using inverse probability of treatment weights.
Results: We performed Monte Carlo simulations to test the performance of our method. The results show that our method estimated adjusted net benefits in an unbiased manner regardless of whether the assumption of proportional hazards held. In addition, we illustrated our method using data from an observational study evaluating disease-free survival of Ewing’s sarcoma patients. Our method yielded an adjusted net benefit of –0.032, whereas an existing method, used to analyze data from randomized trials, yielded an unadjusted net benefit of 0.284.
Conclusions: In observational studies with a time-to-event outcome, the net benefit adjusted for confounding can readily be estimated using inverse probability of treatment weights.
Full Text:
PDFDOI: https://doi.org/10.2427/12993
NBN: http://nbn.depositolegale.it/urn%3Anbn%3Ait%3Aprex-24029
References
Article Metrics
Metrics powered by PLOS ALM
Refbacks
- There are currently no refbacks.
Copyright (c) 2013 Epidemiology, Biostatistics and Public Health

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
EBPH Epidemiology, Biostatistics and Public Health | ISSN 2282-0930

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.